Showing results (11-20 of 103) with videos related to
Sort By:
Pageof 11
Annual Review of Pathology|November 16, 2020
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and ResistanceSreya Bagchi, Robert Yuan, Edgar G EnglemanHuman Vaccines & Immunotherapeutics|January 28, 2015
Potential for immunotherapy in soft tissue sarcomaWilliam W Tseng, Neeta Somaiah, Edgar G EnglemanJournal of Immunology (Baltimore, Md. : 1950)|December 22, 2010
Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subsetPia Björck, H Xianne Leong, Edgar G EnglemanThe Journal of Clinical Investigation|March 3, 2004
Induction of potent antitumor immunity by in situ targeting of intratumoral DCsKatsuyoshi Furumoto, Luis Soares, Edgar G Engleman, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunityFumiyoshi Okano, Miriam Merad, Katsuyoshi Furumoto, et al.Blood|February 28, 2002
In vivo manipulation of dendritic cells to induce therapeutic immunityMiriam Merad, Tomoharu Sugie, Edgar G Engleman, et al.Trends in Immunology|May 16, 2026
Rethinking the origins and functions of adaptive immunityDerick Okwan-Duodu, Erik A Sperling, Edgar G EnglemanMolecular Pharmaceutics|May 7, 2009
In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccinesTristan T Beaudette, Eric M Bachelder, Joel A Cohen, et al.Blood|January 19, 2017
Tolerogenic interactions between CD8<sup>+</sup> dendritic cells and NKT cells prevent rejection of bone marrow and organ graftsDavid Hongo, Xiaobin Tang, Xiangyue Zhang, et al.Pageof 11